Want to create an interactive transcript for this episode?
Podcast: PeerView Clinical Pharmacology CME/CNE/CPE Video
Episode: Vivian Y. Shi, MD, FAAD - Hope on the Horizon for Hidradenitis Suppurativa: Leveraging Emerging Biologics to Improve Quality of Life
Description: Go online to PeerView.com/RJF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hidradenitis suppurativa (HS) is a chronic, inflammatory dermatologic condition characterized by the occurrence of suppurative, painful lesions, typically in the intertriginous areas. Diagnostic delay is common and is correlated with an increase in disease severity and a decrease in quality of life. While existing treatments are often inadequate and do not help all patients, one biologic agent is approved for the management of HS and a number of other emerging agents are currently undergoing phase 2 and 3 trials. In...